Kamada (KMDA) Short-term Investments (2012 - 2026)
Kamada (KMDA) posted quarterly Short-term Investments of $40.2 million for Q1 2026, up 20318.78% on a QoQ basis from $197000.0 in Q4 2025.
Kamada (KMDA) Short-term Investments (2012 - 2026) Analysis & Trends
Kamada (KMDA) has reported Short-term Investments for 15 consecutive years, with $40.2 million the latest figure, recorded in Q1 2026.
- Quarterly Short-term Investments changed N/A year-over-year to $40.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $40.2 million (changed N/A YoY) and the FY2025 annual result came in at $197000.0, up 302.04% from the prior year.
- Short-term Investments improved to $40.2 million in Q1 2026 per KMDA's latest filing, from $197000.0 in the prior quarter.
- Over the last five years, Short-term Investments for KMDA reached as high as $40.2 million in Q1 2026 and fell as low as $4000.0 in Q4 2022.
- A 5-year average of $8.1 million and a median of $149000.0 in 2023 frame the typical range for Short-term Investments.
- Annual changes were most pronounced in 2022 — Short-term Investments slumped 100.0% — and 2023, when it soared 3625.0%.
- Year by year, Short-term Investments stood at $4000.0 in 2022, then surged by 3625.0% to $149000.0 in 2023, then sank by 67.11% to $49000.0 in 2024, then soared by 302.04% to $197000.0 in 2025, then jumped by 20318.78% to $40.2 million in 2026.
- According to Business Quant data, Short-term Investments over the past three periods registered $40.2 million, $197000.0, and $49000.0 for Q1 2026, Q4 2025, and Q4 2024 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | Kamada | 401.22 Mn | 328.07 Mn | 19.12 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 40.23 Mn |
| Dec 31, 2025 | 197,000.00 |
| Dec 31, 2024 | 49,000.00 |
| Dec 31, 2023 | 149,000.00 |
| Dec 31, 2022 | 4,000.00 |
| Dec 31, 2021 | 126.71 Mn |
| Jun 30, 2021 | 36.14 Mn |
| Mar 31, 2021 | 48.04 Mn |
| Dec 31, 2020 | 39.07 Mn |
| Sep 30, 2020 | 47.23 Mn |
| Jun 30, 2020 | 47.27 Mn |
| Mar 31, 2020 | 47.12 Mn |
| Dec 31, 2019 | 31.25 Mn |
| Sep 30, 2019 | 39.38 Mn |
| Jun 30, 2019 | 38.12 Mn |
| Mar 31, 2019 | 33.80 Mn |
| Dec 31, 2018 | 32.50 Mn |
| Sep 30, 2018 | 32.05 Mn |
| Jun 30, 2018 | 32.23 Mn |
| Mar 31, 2018 | 30.45 Mn |